In fact, RNA sequencing (RNA‐seq) analysis in diverse immune cell types (i.e., CD4+, CD8+, and CD14+ cells) identified a differential lncRNA expression profile between healthy subjects and stage IV CM patients, which usually develop resistance upon immunotherapy treatment. Here, CD8A is linked to cutaneous mastocytosis.